BioCatalystWatch
SLDBWorkspace / SLDB / OverviewCompany library
Solid Biosciences Inc. logo

Solid Biosciences Inc.

Solid Biosciences Inc. (SLDB)

Website

Price
Market cap
Next catalystLate Q4 2026SGT-003 — INSPIRE DUCHENNE · Regulatory meetingCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

SGT-212

FXN (full-length frataxin)

PreINDP1P2P3FilingApproved
Upcoming / outlook

SGT-501

CASQ2 (cardiac calsequestrin)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SGT-003

Integrin receptors × Microdystrophin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SGT-601

Gene therapy

TNNT2 transgene

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

SGT-601

Gene therapy

TNNT2 transgene

Upcoming / outlook

SGT-003

Integrin receptors × Microdystrophin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SGT-501

CASQ2 (cardiac calsequestrin)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

SGT-212

FXN (full-length frataxin)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

SGT-003

Integrin receptors × Microdystrophin

PreINDP1P2P3FilingApproved
AVB-202-TT

FXN (frataxin)

PreINDP1P2P3FilingApproved

Partner / License out

Approved / commercial

History / paused

Microdystrophin

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

SLDB PR & News

PR & News

SLDB SEC archive